Literature DB >> 12847068

Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase.

Steffen-Sebastian Bolz1, Lukas Vogel, Daniel Sollinger, Roland Derwand, Christa Boer, Stuart M Pitson, Sarah Spiegel, Ulrich Pohl.   

Abstract

BACKGROUND: RhoA and Rho kinase are important modulators of microvascular tone. METHODS AND
RESULTS: We tested whether sphingosine kinase (Sphk1) that generates the endogenous sphingolipid mediator sphingosine-1-phosphate (S1P) is part of a signaling cascade to activate the RhoA/Rho kinase pathway. Using a new transfection model, we report that resting tone and myogenic responses of isolated resistance arteries increased with forced expression of Sphk1 in smooth muscle cells of these arteries. Overexpression of a dominant negative Sphk1 mutant or coexpression of dominant negative mutants of RhoA or Rho kinase together with Sphk1 completely inhibited development of tone and myogenic responses.
CONCLUSIONS: The tone-increasing effects of a Sphk1 overexpression suggest that Sphk1 may play an important role in the control of peripheral resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847068     DOI: 10.1161/01.CIR.0000080324.12530.0D

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  52 in total

1.  Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats.

Authors:  D G Hemmings; Y Xu; S T Davidge
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

2.  A microfluidic platform for probing small artery structure and function.

Authors:  Axel Günther; Sanjesh Yasotharan; Andrei Vagaon; Conrad Lochovsky; Sascha Pinto; Jingli Yang; Calvin Lau; Julia Voigtlaender-Bolz; Steffen-Sebastian Bolz
Journal:  Lab Chip       Date:  2010-07-06       Impact factor: 6.799

3.  Inhibition of Sphingosine Kinase 1 Ameliorates Angiotensin II-Induced Hypertension and Inhibits Transmembrane Calcium Entry via Store-Operated Calcium Channel.

Authors:  Parker C Wilson; Wayne R Fitzgibbon; Sara M Garrett; Ayad A Jaffa; Louis M Luttrell; Michael W Brands; Hesham M El-Shewy
Journal:  Mol Endocrinol       Date:  2015-04-14

Review 4.  Regulation and functional roles of sphingosine kinases.

Authors:  Regina Alemany; Chris J van Koppen; Kerstin Danneberg; Michael Ter Braak; Dagmar Meyer Zu Heringdorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-23       Impact factor: 3.000

Review 5.  Role of rho kinase in the functional and dysfunctional tonic smooth muscles.

Authors:  Márcio A F de Godoy; Satish Rattan
Journal:  Trends Pharmacol Sci       Date:  2011-04-15       Impact factor: 14.819

6.  Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.

Authors:  Vladimir Beljanski; Christian Knaak; Yan Zhuang; Charles D Smith
Journal:  Invest New Drugs       Date:  2010-05-18       Impact factor: 3.850

7.  Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone.

Authors:  Bernhard Friedrich Peter; Darcy Lidington; Aki Harada; Hanno Jörn Bolz; Lukas Vogel; Scott Heximer; Sarah Spiegel; Ulrich Pohl; Steffen-Sebastian Bolz
Journal:  Circ Res       Date:  2008-06-26       Impact factor: 17.367

Review 8.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

Review 9.  Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.

Authors:  Linda Sasset; Yi Zhang; Teresa M Dunn; Annarita Di Lorenzo
Journal:  Trends Endocrinol Metab       Date:  2016-08-22       Impact factor: 12.015

Review 10.  The vascular S1P gradient-cellular sources and biological significance.

Authors:  Timothy Hla; Krishnan Venkataraman; Jason Michaud
Journal:  Biochim Biophys Acta       Date:  2008-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.